Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2010
07/01/2010CA2747996A1 Compounds and methods for enhancing erythropoiesis
07/01/2010CA2747992A1 Dosage regimen of an s1p receptor agonist
07/01/2010CA2747957A1 Compounds and methods for the treatment of pain and other diseases
07/01/2010CA2747955A1 Implantable devices for treating hiv
07/01/2010CA2747939A1 A composition and method of treating skin conditions.
07/01/2010CA2747938A1 Immunostimulating saponins for use in in situ tumor-destruction therapy
07/01/2010CA2747932A1 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives
07/01/2010CA2747925A1 Dihydropyridone amides as p2x7 modulators
07/01/2010CA2747917A1 Compositions of topical ocular solutions to deliver effective concentrations of active agent to the posterior segment of the eye
07/01/2010CA2747863A1 Pyridazinone derivatives
07/01/2010CA2747817A1 Selective inhibitors of akt and methods of using same
07/01/2010CA2747811A1 Coumarin-based compounds
07/01/2010CA2747809A1 Bicyclic heterocycle derivatives and methods of use thereof
07/01/2010CA2747807A1 Pyrimidine derivatives and methods of use thereof
07/01/2010CA2747805A1 Methods for treating or preventing cancer and neurodegenerative diseases
07/01/2010CA2747802A1 Dosage regimen for a s1p receptor agonist
07/01/2010CA2747795A1 Isoquinoline derivative
07/01/2010CA2747784A1 Pharmaceutical compounds
07/01/2010CA2747770A1 Melanin production inhibitor
07/01/2010CA2747750A1 Gamma secretase modulators
07/01/2010CA2747744A1 Gamma secretase modulators
07/01/2010CA2747681A1 Polyunsaturated fatty acid and diol ester as an anti-acne agent
07/01/2010CA2747418A1 Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents
07/01/2010CA2747390A1 Apparatus and methods for containing and delivering therapeutic agents
07/01/2010CA2747326A1 Combination of aurora kinase inhibitors and anti-cd20 antibodies
07/01/2010CA2747055A1 Substituted benzimidazole derivatives as protein kinase inhibitors
07/01/2010CA2746966A1 Maintenance fluid for animals
07/01/2010CA2746887A1 Methods for enhancing the release and absorption of water insoluble active agents
07/01/2010CA2746884A1 A method of treating insomnia
07/01/2010CA2746834A1 Antiviral compounds
07/01/2010CA2746831A1 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging
07/01/2010CA2746727A1 Amino acid ester prodrugs and the use thereof
07/01/2010CA2746711A1 Dipeptoid prodrugs and the use thereof
07/01/2010CA2746561A1 Dihydropyridone amides as p2x7 modulators
07/01/2010CA2746132A1 Beer and beer-based beverages and method of modification of polyphenols and silicon content in these beverages
07/01/2010CA2746085A1 Enzastaurin for the treatment of cancer
07/01/2010CA2746055A1 Triple reuptake inhibitors and methods of their use
07/01/2010CA2745952A1 Dihydropyridone amides as p2x7 modulators
07/01/2010CA2745901A1 Compositions and methods for inhibition of the jak pathway
07/01/2010CA2745866A1 Dihydropyridone ureas as p2x7 modulators
07/01/2010CA2745865A1 Heterocyclic antiviral compounds
07/01/2010CA2745864A1 Dihydropyridone amides as p2x7 modulators
07/01/2010CA2745457A1 Topical pharmaceutical composition containing a water-sensitive active principle
07/01/2010CA2745020A1 Phytoestrogenic compositions for preventing or treating symptoms associated with menopause
07/01/2010CA2744898A1 Topical formulations of flap inhibitors for administration to an eye
07/01/2010CA2744714A1 Amino pyrazole compound
07/01/2010CA2740195A1 Anti-viral compounds
07/01/2010CA2740193A1 Anti-viral compounds
07/01/2010CA2728118A1 Compounds for treatment of cancer
06/2010
06/30/2010EP2202293A2 New mutactimycin and aldgamycin active compounds and the use thereof in therapy
06/30/2010EP2202242A1 Inactivation resistant factor VIII related applications
06/30/2010EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform
06/30/2010EP2202240A1 Compound
06/30/2010EP2202239A1 RNAI inhibition of influenza virus replication
06/30/2010EP2202237A1 Hydrosoluble [6)-O-alpha-d-glcp-(1->]n-6-o-bêta-d-glcp-(1->-phenllic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds
06/30/2010EP2202235A1 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof
06/30/2010EP2202233A1 Method for producing pyrazole fused ring derivative
06/30/2010EP2202232A1 1,2,4-oxadiazole derivatives and their therapeutic use
06/30/2010EP2202231A1 2,3-dihydroiminoisoindole derivative
06/30/2010EP2202230A1 Competitive inhibitors of type ii dehydroquinase enzyme
06/30/2010EP2202229A1 Novel preparation for external use
06/30/2010EP2202228A1 Amide compounds and use of the same
06/30/2010EP2202227A1 Novel histidine derivative
06/30/2010EP2202225A1 New method for synthesising ivabradine and its added salts with a pharmaceutically acceptable acid.
06/30/2010EP2202222A2 Indene derivatives, their preparation and use as medicaments
06/30/2010EP2202216A1 Spiro-ring compound and use thereof for medical purposes
06/30/2010EP2201982A1 Histamine H4 receptor antagonists for the treatment of vestibular disorders
06/30/2010EP2201965A1 Intraluminal device with a coating containing a therapeutic agent
06/30/2010EP2201964A2 Formoterol superfine formulation
06/30/2010EP2201953A1 Use of ribavirin in blood coagulation disorder
06/30/2010EP2201952A1 Omeprazole dosage forms and their use
06/30/2010EP2201951A1 Octenidine composition
06/30/2010EP2201950A1 Compounds and methods for treating autism spectrum disorders
06/30/2010EP2201949A1 Pharmaceutical composition combining betamethasone (steroidal anti-inflammatory agent) and methocarbamol (muscle relaxant) and use thereof in the treatment of musculoskeletal diseases
06/30/2010EP2201948A1 Maintenance fluid for animals
06/30/2010EP2201947A2 Use of SAHA for treating mesothelioma
06/30/2010EP2201946A1 Pai-1 production inhibitor
06/30/2010EP2201945A2 Substituted 2-Aminoacetamides and the Use Thereof
06/30/2010EP2201944A2 Substituted 2-Aminoacetamides and the Use Thereof
06/30/2010EP2201943A1 Novel use of a peptide class of compounds for treating diabetic neuropathic pain
06/30/2010EP2201942A1 Compound with hemp oil for the treatment of topical illnesses
06/30/2010EP2201939A1 Method for producing coated spiramycin and novel formulations containing the same
06/30/2010EP2201937A1 Formulations comprising vitamin D or derivatives thereof
06/30/2010EP2201936A1 Method of treating acute rhinosinusitis
06/30/2010EP2201934A1 Tiotropium aerosol formulation products with improved chemical stability
06/30/2010EP2201897A2 Tumor targeted photodiagnostic-phototherapeutic agents
06/30/2010EP2201840A1 Inhibitors of Bruton's Tyrosine Kinase
06/30/2010EP2201372A2 Novel therapeutic targets in bowel disease
06/30/2010EP2201118A2 Compositions and methods for the identification of inhibitors of retroviral infection
06/30/2010EP2201116A1 Means and methods for shrna mediated conditional knockdown of genes
06/30/2010EP2201025A1 Functional lipid constructs
06/30/2010EP2201018A2 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-ý7-(2-morpholin-4-yl-ethoxy)imidazoý2,1-b¨ý1,3¨benzothiazol-2-yl¨phenyl}urea, compositions thereof, and uses therewith
06/30/2010EP2201017A1 Artemisinin derivatives for the treatment of melanoma
06/30/2010EP2201015A2 Process for producing carnosol from carnosic acid using hydrogen peroxide or peracids
06/30/2010EP2201014A1 Process for producing carnosol from carnosic acid
06/30/2010EP2201012A1 Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors
06/30/2010EP2201011A2 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same
06/30/2010EP2201010A1 Modulators of cystic fibrosis transmembrane conductance regulator
06/30/2010EP2201008A1 Pyridyl sulfonamides as modulators of ion channels
06/30/2010EP2201007A1 Cannabinoid receptor ligands
1 ... 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 ... 7860